Melanoma: The Milan Melanoma Cell Lines
暂无分享,去创建一个
A. Anichini | G. Parmiani | A. Molla | C. Vegetti | R. Mortarini | A. Borri
[1] S. Aamdal,et al. Correlation of DNA ploidy and S‐phase fraction with chemotherapeutic response and survival in a randomized study of disseminated malignant melanoma , 1996, International journal of cancer.
[2] A. Anichini,et al. Cytotoxic T cells directed to tumor antigens not expressed on normal melanocytes dominate HLA-A2.1-restricted immune repertoire to melanoma. , 1996, Journal of immunology.
[3] M. Herlyn,et al. Mitogenic activity of laminin on human melanoma and melanocytes: different signal requirements and role of beta 1 integrins. , 1995, Cancer research.
[4] E. Dejana,et al. Involvement of the very late antigen 4 integrin on melanoma in interleukin 1-augmented experimental metastases. , 1995, Cancer research.
[5] A. Anichini,et al. Expression of Interleukin 1α, Interleukin 6, and Tumor Necrosis Factor α Genes in Human Melanoma Clones Is Associated with That of Mutated N-RAS Oncogene , 1994 .
[6] M. Herlyn,et al. Expression of cytokine/growth factors and their receptors in human melanoma and melanocytes , 1994, International journal of cancer.
[7] A. Anichini,et al. N-RAS mutations and susceptibility to lymphokine-activated killer (LAK) cells in human melanoma , 1994, Melanoma research.
[8] M. Herlyn,et al. Melanoma cells and normal melanocytes share antigens recognized by HLA- A2-restricted cytotoxic T cell clones from melanoma patients , 1993, The Journal of experimental medicine.
[9] S. Bernasconi,et al. Regulated expression of vascular cell adhesion molecule-1 in human malignant melanoma. , 1992, The American journal of pathology.
[10] A. Mantovani,et al. Heterogeneous susceptibility of human melanoma clones to monocyte cytotoxicity: Role of ICAM‐1 defined by antibody blocking and gene transfer , 1992, European journal of immunology.
[11] A. Santoni,et al. Role of the α5β1 Integrin Receptor in the Proliferative Response of Quiescent Human Melanoma Cells to Fibronectin , 1992 .
[12] A. Mantovani,et al. Heterogeneity in human melanoma cell adhesion to cytokine activated endothelial cells correlates with VLA-4 expression. , 1991, Cancer research.
[13] A. Anichini,et al. Cytokine‐mediated modulation of HLA‐class II, ICAM‐1, LFA‐3 and tumor‐associated antigen profile of melanoma cells. comparison with anti‐proliferative activity by RIL1‐β, RTNF‐α, RIFN‐γ, RIl4 and their combinations , 1990 .
[14] A. Anichini,et al. Heterogeneity of clones from a human metastatic melanoma detected by autologous cytotoxic T lymphocyte clones , 1986, The Journal of experimental medicine.
[15] A. Anichini,et al. Clonal analysis of cytotoxic T‐lymphocyte response to autologous human metastatic melanoma , 1985, International journal of cancer.
[16] G. Sozzi,et al. Chromosome abnormalities and fragile sites in human melanoma. , 1990, Cancer genetics and cytogenetics.
[17] G. Parmiani,et al. Tumorigenicity and dissemination of primary and metastatic human melanomas implanted into different sites in athymic nude mice. , 1988, Invasion & metastasis.